Physician profile
Alan Lim
NPI 1659341709
$2,050.50
in general payments reported to CMS, 2019-2025
12 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.73 · 2022: $209 · 2023: $436 · 2024: $762 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $317.71 | 2024-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Integra Lifesciences Corporation | $267.32 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $259.80 | 2023-2024 | |
| Mimedx Group, INC. | $162.78 | 2024 | |
| Tela Bio, INC. | $158.81 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $156.52 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Smith+Nephew, INC. | $156.20 | 2023 | Renasys Go V2 Home, Renasys Touch, Pico |
| Biocomposites INC | $147.76 | 2025 | Stimulan |
| Mentor Worldwide LLC | $147.43 | 2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Depuy Synthes Sales INC. | $138.18 | 2025 | Matrixwave, Matrixmandible |
| Allergan, INC. | $77.26 | 2022 | |
| Sientra, INC. | $60.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.